SummaryThis clinical case reports the emergence of a daptomycin-resistant Staphylococcus aureus isolate during daptomycin treatment in a patient with right-sided infective endocarditis who had never been treated with vancomycin
Background: Daptomycin is a cyclic lipopeptide with potent activity and broad spectrum against Gram-...
The best therapeutic approach for treating MRSA endocarditis remains unknown, particularly in cases ...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
peer-reviewedIntroduction: Ireland currently has the highest reported rate in Europe of vancomycin-r...
BACKGROUND: Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed. ...
Daptomycin is an intravenous, cycliclipopeptide exhibiting concentra-tion-dependent killing against ...
This case report describes a methicillin-resistant Staphylococcus aureus isolated repeatedly from th...
We report a case series of 11 patients with severe E. faecium infections treated with daptomycin. Al...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
Abstract Coagulase-negative staphylococci (CoNS) have been increasing in importance as a cause of na...
ABSTRACTNumerous surveillance studies confirm that methicillin resistance is common among isolates o...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureu...
Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin...
Methicillin-resistant S. aureus (MRSA) with low susceptibility to glycopeptides is uncommon. CASE P...
Background: Daptomycin is a cyclic lipopeptide with potent activity and broad spectrum against Gram-...
The best therapeutic approach for treating MRSA endocarditis remains unknown, particularly in cases ...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
peer-reviewedIntroduction: Ireland currently has the highest reported rate in Europe of vancomycin-r...
BACKGROUND: Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed. ...
Daptomycin is an intravenous, cycliclipopeptide exhibiting concentra-tion-dependent killing against ...
This case report describes a methicillin-resistant Staphylococcus aureus isolated repeatedly from th...
We report a case series of 11 patients with severe E. faecium infections treated with daptomycin. Al...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
Abstract Coagulase-negative staphylococci (CoNS) have been increasing in importance as a cause of na...
ABSTRACTNumerous surveillance studies confirm that methicillin resistance is common among isolates o...
A patient developed a daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infect...
We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureu...
Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin...
Methicillin-resistant S. aureus (MRSA) with low susceptibility to glycopeptides is uncommon. CASE P...
Background: Daptomycin is a cyclic lipopeptide with potent activity and broad spectrum against Gram-...
The best therapeutic approach for treating MRSA endocarditis remains unknown, particularly in cases ...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...